Literature DB >> 17050026

Novel polymeric microspheres containing norcantharidin for chemoembolization.

Xiaohua Liu1, Wan Sia Heng, Qi Li, Lai Wah Chan.   

Abstract

Chemoembolization has been found to be a potentially effective method of treating certain types of cancer. It involves arterial embolization of a tumor, in combination with simultaneous or subsequent local delivery of chemotherapeutic agents. In this study, PLGA-alginate microspheres were evaluated for their potential application in chemoembolization. Norcantharidin, which possesses anti-tumor properties, was used to investigate the application of drug-containing microspheres for chemoembolization. The release profiles of alginate, PLGA and PLGA-alginate microspheres were markedly different in phosphate buffered saline, with the composite microspheres showing the most appropriate release rate for chemoembolization. Burst effect decreased while particle size increased with increasing proportion of alginate in the PLGA-alginate microspheres. PLGA-alginate microspheres containing norcantharidin were effective in destroying the cancer cells used in this study. The growth inhibitory effect was concentration and time dependent. These microspheres also exhibited excellent embolization and therapeutic effects on rats with transplanted tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050026     DOI: 10.1016/j.jconrel.2006.08.022

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

Review 1.  Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers.

Authors:  Jesse B Wolinsky; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2011-12-01       Impact factor: 9.776

2.  Synthesis and characterization of polystyrene embolization particles doped with tantalum oxide nanoparticles for X-ray contrast.

Authors:  Rachel Morrison; James Thompson; Luke Bird; Mark A Hill; Helen Townley
Journal:  J Mater Sci Mater Med       Date:  2015-07-30       Impact factor: 3.896

3.  Incorporation of ophiobolin a into novel chemoembolization particles for cancer cell treatment.

Authors:  Rachel Morrison; Chris Gardiner; Antonio Evidente; Robert Kiss; Helen Townley
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

4.  Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS.

Authors:  Xin-Yuan Ding; Cheng-Jiao Hong; Yang Liu; Zong-Lin Gu; Kong-Lang Xing; Ai-Jun Zhu; Wei-Liang Chen; Lin-Seng Shi; Xue-Nong Zhang; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2012-04-02

Review 5.  Flexible polymeric patch based nanotherapeutics against non-cancer therapy.

Authors:  Houjuan Zhu; Justin Mah Jian Qiang; Chen Gang Wang; Chui Yu Chan; Qiang Zhu; Enyi Ye; Zibiao Li; Xian Jun Loh
Journal:  Bioact Mater       Date:  2022-03-30

Review 6.  Therapeutic application of hydrogels for bone-related diseases.

Authors:  Xiyu Liu; Shuoshuo Sun; Nan Wang; Ran Kang; Lin Xie; Xin Liu
Journal:  Front Bioeng Biotechnol       Date:  2022-09-12

7.  MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors.

Authors:  Dong-Hyun Kim; Jeane Chen; Reed A Omary; Andrew C Larson
Journal:  Theranostics       Date:  2015-02-07       Impact factor: 11.556

8.  Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.

Authors:  Min-Chen Liu; Lin Liu; Xia-Rong Wang; Wu-Ping Shuai; Ying Hu; Min Han; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2016-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.